AKBA · Akebia Therapeutics, Inc.
SELL 91%
43
Total trades
17
Insiders on record
91%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Feb 2, 2026 | Nicholas Grund | SELL | Open-market sale | 74.5K | 0.93 |
| Feb 2, 2026 | Steven Keith Burke | SELL | Open-market sale | 30K | 0.93 |
| Feb 2, 2026 | Carolyn Rucci | SELL | Open-market sale | 23.4K | 0.93 |
| Feb 2, 2026 | Richard C Malabre | SELL | Open-market sale | 50.2K | 0.88 |
| Feb 2, 2026 | John Butler | SELL | Open-market sale | 64.9K | 0.97 |
| Jun 30, 2025 | Erik Ostrowski | SELL | Open-market sale | 151.6K | 0.99 |
| Jun 9, 2025 | Richard C Malabre | SELL | Open-market sale | 60.2K | 0.87 |
| Jun 4, 2025 | Richard C Malabre | SELL | Open-market sale | 47.1K | 0.87 |
| Mar 3, 2025 | John Butler | SELL | Open-market sale | 84.9K | 0.98 |
| Mar 3, 2025 | Steven Keith Burke | SELL | Open-market sale | 13.1K | 0.88 |
Akebia Therapeutics, Inc. has 43 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade AKBA?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.